Advances in radiotherapy in 2020: Hypofractionation - less is more in times of COVID-19
Indian Journal of Cancer 2021 58(1):41-44 (Source: Indian Journal of Cancer)
Source: Indian Journal of Cancer - March 24, 2021 Category: Cancer & Oncology Source Type: research
Advances in surgery in 2020: The impact of the COVID-19 pandemic on cancer surgeries and cancer care - a brief overview
Indian Journal of Cancer 2021 58(1):38-40 (Source: Indian Journal of Cancer)
Source: Indian Journal of Cancer - March 24, 2021 Category: Cancer & Oncology Source Type: research
Advances in breast cancer research in 2020: changes in clinical practice
Indian Journal of Cancer 2021 58(1):35-37 (Source: Indian Journal of Cancer)
Source: Indian Journal of Cancer - March 24, 2021 Category: Cancer & Oncology Source Type: research
Advances in pathology in 2020: Year & #39;s roundup
Indian Journal of Cancer 2021 58(1):32-34 (Source: Indian Journal of Cancer)
Source: Indian Journal of Cancer - March 24, 2021 Category: Cancer & Oncology Source Type: research
Advances in community oncology in 2020: COVID-19 and beyond
Indian Journal of Cancer 2021 58(1):30-31 (Source: Indian Journal of Cancer)
Source: Indian Journal of Cancer - March 24, 2021 Category: Cancer & Oncology Source Type: research
Advances in basic research in oncology in 2020: Bridging basic science and clinical care
Indian Journal of Cancer 2021 58(1):28-29 (Source: Indian Journal of Cancer)
Source: Indian Journal of Cancer - March 24, 2021 Category: Cancer & Oncology Source Type: research
Grossing and reporting of a soft tissue tumor specimen in surgical pathology: Rationale, current evidence, and recommendations
This article focuses on the grossing of soft tissue tumors, including sarcomas, in terms of types of specimens, grossing techniques including rationale, tissue triage, reporting, and recommendations from the surgical pathologists actively engaged in reporting musculoskeletal tumors,
based on current evidence. (Source: Indian Journal of Cancer)
Source: Indian Journal of Cancer - March 24, 2021 Category: Cancer & Oncology Authors: Bharat Rekhi Jayasree Kattoor Anne Jennifer Nandini Govindarajan Shantveer Uppin Nirmala A Jambhekar Annie Jojo Uttara Chatterjee Devmalya Banerjee Pradyumn Singh Source Type: research
Optimum patient selection for irinotecan-containing regimens in metastatic colorectal cancer: Literature review and lessons from clinical practice
Maheboob Basade, Akshata ManeIndian Journal of Cancer 2021 58(1):5-16
Metastatic colorectal cancer (mCRC) accounts for over 20% of CRC cases and is associated with a poor prognosis. Irinotecan is an important first- and second-line chemotherapy option for mCRC. In this review, we summarize the clinical efficacy and safety of irinotecan-based regimens for the treatment of mCRC and discuss various tumor- and patient-related factors that affect the clinical response, survival, and toxicity associated with these regimens. Uridine diphosphate glucuronosyltransferase (UGT) gene polymorphisms such as UGT1A1*...
Source: Indian Journal of Cancer - March 24, 2021 Category: Cancer & Oncology Authors: Maheboob Basade Akshata Mane Source Type: research
Epidermal growth factor receptor mutated lung cancers: Looking beyond adenocarcinomas
Saurabh ZanwarIndian Journal of Cancer 2021 58(1):3-4 (Source: Indian Journal of Cancer)
Source: Indian Journal of Cancer - March 24, 2021 Category: Cancer & Oncology Authors: Saurabh Zanwar Source Type: research
Outgoing editor & #39;s thoughts & #8211; On Sisyphean tasks and the last refuge of scoundrels
Sanjay A PaiIndian Journal of Cancer 2021 58(1):1-2 (Source: Indian Journal of Cancer)
Source: Indian Journal of Cancer - March 24, 2021 Category: Cancer & Oncology Authors: Sanjay A Pai Source Type: research
Cancer research recognized (and ignored) by the Nobel prizes
Sachi Sri KanthaIndian Journal of Cancer 2020 57(4):376-377 (Source: Indian Journal of Cancer)
Source: Indian Journal of Cancer - October 17, 2020 Category: Cancer & Oncology Authors: Sachi Sri Kantha Source Type: research
Important milestones for cancer at the Nobel prize
Ozgur Tanriverdi, Muhammed Tasar, Mustafa Yilmaz, Melih Furkan Durak, Selin Beyza Sezer, Hatice Demir, Muesser OzcanIndian Journal of Cancer 2020 57(4):370-375
The Nobel Prize, which is awarded annually, is open to everyone, regardless of nationality, race, belief or ideology, and winners are announced in October. We evaluated the history of the Nobel prizes for awards that have been awarded in fields related to cancer. The contents of the research and their contribution to oncology were determined and reviewed. There were nine awards directly related to cancer. Only studies thought to be groundbreaking in carcinogenesis ...
Source: Indian Journal of Cancer - October 17, 2020 Category: Cancer & Oncology Authors: Ozgur Tanriverdi Muhammed Tasar Mustafa Yilmaz Melih Furkan Durak Selin Beyza Sezer Hatice Demir Muesser Ozcan Source Type: research
News from the world of oncology
Indian Journal of Cancer 2020 57(4):507-509 (Source: Indian Journal of Cancer)
Source: Indian Journal of Cancer - October 17, 2020 Category: Cancer & Oncology Source Type: research
Not all blast flags in hematology analysers are leukemia - think malaria!
Jayashree D Kulkarni, Rajesh Singh, PS PramodIndian Journal of Cancer 2020 57(4):505-506 (Source: Indian Journal of Cancer)
Source: Indian Journal of Cancer - October 17, 2020 Category: Cancer & Oncology Authors: Jayashree D Kulkarni Rajesh Singh PS Pramod Source Type: research
Barrier devices for aerosol-generating procedure during COVID-19 pandemic
Vinod Kumar, Nishkarsh GuptaIndian Journal of Cancer 2020 57(4):502-504 (Source: Indian Journal of Cancer)
Source: Indian Journal of Cancer - October 17, 2020 Category: Cancer & Oncology Authors: Vinod Kumar Nishkarsh Gupta Source Type: research
